Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Sponsored Content | Blog | Greg Freiherr, Industry Consultant | Contrast Media | October 15, 2019

BLOG: How Customer Needs Impact Product Innovation

A volume of contrast agent lingers near the injection site, creating an artifact that can block the visualization of structures

A volume of contrast agent lingers near the injection site, creating an artifact that can block the visualization of structures. Graphic courtesy of Lior Molvin

When it comes to listing needs, patient safety ranks at the top. Just ask an imaging administrator.

“There is no way we can provide good quality customer care any other way,” said Brent Purscelley, director of ambulatory services at the Frederick Regional Health System.

But even when it comes to patient safety, distinguishing between needs and wants can get tricky. This is especially so when the frequency of patient complications gets very low.

Take CT contrast extravasations, for example. The leakage of contrast media from an intended blood vessel occurs very infrequently, only between 0.1 and 1.2 percent of administrations, according to the 2018 edition of the American College of Radiology (ACR) Manual on Contrast Media (version 10.3). Severe injuries due to extravasation may occur even more rarely.

“We have the technology today to monitor patients via sensors,” Purscelley said, “but it (extravasation) doesn’t happen often enough to really justify spending the additional money to do (the monitoring).”

The Role Of Smart Injectors

That’s where “smart” injectors come in. Not only do they alert technologists to ongoing problems, but –like black boxes on commercial airliners – they can record the data surrounding events, helping administrators understand the circumstances that led to them. Applied with preventative measures, these smart injectors can make a huge difference in patient safety.

To reduce the risk of extravasation, technologists at Frederick Regional Health System use a large gauge IV needle and tube; make sure needle placement is optimal; and assess patients for risk factors prior to contrast-enhanced scans, according to Christopher Nield, imaging supervisor there. The techs also use saline to test IV lines for stability prior to the injection of contrast agents. Additionally, the health system uses power injectors that alert techs to events that could indicate an ongoing extravasation.

The amount of time expended to do a procedure is also a factor. Increased turnaround time can decrease patient satisfaction, as it can increase provider and technologist frustration, according to Nield.

Bracco-made injectors record and display data about their performance. The appearance of a pressure spike on an injector display may indicate the occurrence of an extravasation. A networked smart injector can alert techs, radiologists and administrators to an ongoing event. The injector data can be interpreted in the context of the patient’s physical signs and the type of contrast-enhanced examination.

SmartInject solutions, built into Bracco-made injectors, display and document CT and MRI contrast administrations. These injectors can inject saline bolus chasers to push the contrast agent. If such a chaser is not used, a substantial amount of the contrast agent may linger near the injection site, potentially causing artifacts that block the visualization of important structures. Saline injections, before administration of the contrast medium, may also be used to test the stability of the IV needle and its placement in the vein.

Tracking Radiation Dose

Keeping track of radiation dose is critically important to minimizing the amount of patient radiation, which is essential to patient safety. Bracco’s NEXO information system for dose can track patient radiation exposure automatically regardless of the type of imaging system used. The multimodality radiation informatics system monitors and analyzes exposure data in real time and across the enterprise. When those data veer outside set parameters, NEXO sends an alert to physicians, technologists or administrators – whoever the system has been assigned to notify.

Similar capabilities regarding contrast media is achieved with the NEXO Contrast Management System, which uses SmartInject technology. As with the dose-oriented software, NEXO updates patient records by synchronizing with the RIS/PACS, EMR, or voice dictation system used in radiology.

The two systems – one for managing contrast, the other for keeping track of radiation – help meet not only patient needs but needs of the provider. Among provider needs is compliance with requirements, for example, ones set by The Joint Commission.

Because neither MRI nor ultrasound exposes patients to ionizing radiation, their use negates the need to track ionizing radiation, which accompanies CT and radiography/fluoroscopy. Issues surrounding contrast media, however, remain. Providers, therefore, must consider all sorts of risks. Among them is the lack of reliability.

Besides being easy to use, power injectors have to be rugged enough to stand up to the beatings that can be dished out in emergency rooms. Overall reliability, according to Nield, is critically important. “If we have an injector down, the scanner is out for some studies,” he said. “Then we have real issues.”

Editor’s Note: This is the third blog in a series titled Using Contrast Media. The first blog, Why Power Injectors Are Needed for High-quality Imaging, can be found here. The second blog, How Advances in Technology Help Patients and Providers, can be found here. The final blog in this four-part series will consider the value derived from smart injectors and informatics.

 

Related content:

BLOG: Why Power Injectors Are Needed for High-Quality Imaging

BLOG: How Advances in Technology Help Patients and Providers

Manual on Contrast Media

Related Content

The Global Contrast Injectors Market will grow by $613.47M during 2020-2024, according to Technavio
News | Contrast Media Injectors | June 17, 2020
June 17, 2020 — Technavio has been monitoring the ...
The FDA has approved Lilly’s TAUVID (flortaucipir F 18 injection), a radioactive diagnostic agent, for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease

Getty Images

News | Contrast Media | June 01, 2020
June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for...
Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonp

Samples were taken along rivers around Tokyo. Measurements of rare earth element quantities indicate a clearly elevated amount of gadolinium compared to that in natural shale. Graphics courtesy of Tokyo Metropolitan University

News | Magnetic Resonance Imaging (MRI) | May 26, 2020
May 26, 2020 — Researchers from Tokyo Metropolitan...
“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”  —Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

“Everybody cares about radiation dose, but the most sensitive to radiation are children, because they’re growing.”
—Richard Towbin, M.D., Chief of Radiology, Phoenix Children’s Hospital

Sponsored Content | Case Study | Radiation Dose Management | April 09, 2020
Medical imaging plays an increasing role in the accurate diagnosis and treatment of numerous medical conditions.
Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Rising concerns over radiation overexposure teamed with a growing focus on improving the quality of patient care are two key drivers of today’s radiation dose management market. 

Feature | Radiation Dose Management | April 02, 2020 | By Melinda Taschetta-Millane
Rising concerns over...
Gadolinium-based contrast agents

UT Dallas faculty members who collaborated with Dr. Jeremiah Gassensmith (center, back), associate professor of chemistry and biochemistry, include Dr. Lloyd Lumata (left, back), assistant professor of physics, and Dr. Steven Nielsen, associate professor of chemistry. Chemistry graduate students in Gassensmith’s lab include (from left, front) Oliva Brohlin, Arezoo Shahrivarkevishahi and Laurel Hagge.

News | Contrast Media | February 06, 2020
February 6, 2020 — University of Texas at Dallas researchers
This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma

This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma. The quarter dose image on the left was obtained after the administration of 4 ml of MultiHance. Subsequently, an additional 12 ml of MultiHance was administered and the cumulative full dose image in the center was obtained. The image on the right was rendered following artificial intelligence processing of the 4 ml image using eGad genetic algorithms. This image has the quality of triple dose gadolinium even though only one quarter dose gadolinium was given.

Feature | Contrast Media Injectors | January 30, 2020 | By Matthew Kuhn, M.D., FACR
Gadolinium-based contrast agents (...